Novanta Inc

Aktienanalyse zu Novanta Inc (NOVT)

$140.800

+4.266 (+3.03%)Zum Schluss

Loading chart…
Hoch
141.279
Eröffnung
135.220
Volumengewichteter Durchschnittskurs
138.09
Volumen
392.81K
Marktkap.
—
Tief
132.195
Umsatz
54.24M
EV/EBITDA, TTM
22.26

Novanta Inc. is a supplier of core technology solutions, which offer medical and advanced industrial original equipment manufacturers. Its segment includes Automation Enabling Technologies and Medical Solutions. The Automation Enabling Technologies segment designs, manufactures and markets laser beam delivery components, laser beam delivery solutions, CO2 lasers, solid state lasers, ultrafast lasers, optical and inductive encoders, precision motors, integrated stepper motors, servo drives, motion control solutions, intelligent robotic end-of-arm technology solutions, and air bearing spindles to customers worldwide. The Medical Solutions segment designs, manufactures and markets a range of medical grade technologies, including medical insufflators and endoscopic pumps and related disposables, laser beam delivery solutions, video processing and streaming and capture, machine vision technologies, radio frequency identification (RFID) technologies, thermal chart recorders, and others.

www.novanta.com

KI-Analyse of Novanta Inc (NOVT)

Kaufen

Novanta Inc. (NOVT) is a good buy right now, trading at $140.80 with a forward P/E ratio of 8.39, indicating strong earnings potential relative to its price. The stock has shown a 5-day change of +9.33%, suggesting positive momentum. However, insider selling has increased by 134.30%, which is a risk to consider.

Analystenbewertungen (1)

Kaufen
1 Kaufen
0 Halten
0 Verkaufen
Aktuell: 140.80
Tief
—
Durchschnitt
—
Hoch
—

Baird

2026-08-07

Kursziel

$194

Überdurchschnittlich

Baird

2026-05-13

Kursziel

$173

Überdurchschnittlich

Baird

2026-03-30

Kursziel

$144

Überdurchschnittlich

Baird

2026-02-25

Kursziel

$150

Neutral

Baird

2025-08-11

Kursziel

$133

Neutral

Bewertungskennzahlen

Das aktuelle erwartete KGV von Novanta Inc (NOVT) beträgt 8.39, verglichen mit dem 5-Jahres-Durchschnitt von 39.29.

Erwartetes KGV

Stark unterbewertet
5J-Durchschnitt P/E
39.29
Aktuelles P/E
8.39
Überbewertet
54.37
Unterbewertet
24.21

Erwartetes EV/EBITDA

Unterbewertet
5J-Durchschnitt EV/EBITDA
26.85
Aktuelles EV/EBITDA
22.26
Überbewertet
31.23
Unterbewertet
22.48

Erwartetes KUV

Unterbewertet
5J-Durchschnitt P/S
5.43
Aktuelles P/S
3.94
Überbewertet
6.39
Unterbewertet
4.47

Alphio-AI-Kursszenarien für NOVT

Szenariopreise sind das letzte monatliche Prognoseband des laufenden Jahres. Die Wahrscheinlichkeiten sind feste Modellgewichte (25 / 50 / 25), keine Garantien.

B

Bullisch

Bullisch · 25%NOVT

$155.23

Szenariopreis

B

Basis

Basis · 50%NOVT

$145.52

Szenariopreis

B

Bärisch

Bärisch · 25%NOVT

$116.12

Szenariopreis

Whales, die NOVT halten

B

Baron Capital Group, Inc.

+ HältNOVT

+12.16%

3-Monats-Rendite

C

CastleArk Management LLC

+ HältNOVT

+4.66%

3-Monats-Rendite

C

Champlain Investment Partners, LLC

+ HältNOVT

+4.24%

3-Monats-Rendite

S

Southpoint Capital Advisors LP

+ HältNOVT

+3.51%

3-Monats-Rendite

O

Osterweis Capital Management, Inc.

+ HältNOVT

+3.08%

3-Monats-Rendite

F

Fenimore Asset Management, Inc.

+ HältNOVT

-0.58%

3-Monats-Rendite

Event-Zeitleiste

2026-08-05 (ET)

17:00:00

Novanta Reports Q2 Revenue of $265.8 Million

17:00:00

Sees Q3 Revenue of $300M-$304M

17:00:00

Sees FY26 Revenue of $1.13B-$1.14B

2026-07-27 (ET)

08:30:00

Novanta Completes Acquisition of Riverpoint Medical

2026-06-29 (ET)

17:30:00

Selling Stockholders Plan to Sell 2.14M Common Shares

News

NOVT FAQ – beantwortet von Alphio AI

Novanta Inc. is a supplier of core technology solutions, which offer medical and advanced industrial original equipment manufacturers. Its segment includes Automation Enabling Technologies and Medical Solutions. The Automation Enabling Technologies segment designs, manufactures and markets laser beam delivery components, laser beam delivery solutions, CO2 lasers, solid state lasers, ultrafast lasers, optical and inductive encoders, precision motors, integrated stepper motors, servo drives, motion control solutions, intelligent robotic end-of-arm technology solutions, and air bearing spindles to customers worldwide. The Medical Solutions segment designs, manufactures and markets a range of medical grade technologies, including medical insufflators and endoscopic pumps and related disposables, laser beam delivery solutions, video processing and streaming and capture, machine vision technologies, radio frequency identification (RFID) technologies, thermal chart recorders, and others. It operates in the Technology sector (MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT & SU industry).

Novanta Inc. (NOVT) is a good buy right now, trading at $140.80 with a forward P/E ratio of 8.39, indicating strong earnings potential relative to its price. The stock has shown a 5-day change of +9.33%, suggesting positive momentum. However, insider selling has increased by 134.30%, which is a risk to consider.

1 analysts cover NOVT: 1 rate it Buy, 0 Hold and 0 Sell.

Community

Mehr ↗

Noch keine Beiträge

Registriere dich oder melde dich an, um mitzudiskutieren

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Jetzt handeln